PLSE Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (PLSE) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.35 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +17.7% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Pulse Biosciences, Inc.
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients.
Sector
Healthcare
Industry
Medical Instruments/Supply